Neoadjuvant Immunotherapy Being Investigated in Early-Stage NSCLC – OncLive
OncLive |
Neoadjuvant Immunotherapy Being Investigated in Early-Stage NSCLC
OncLive OncLive: What type of data do we have thus far exploring immunotherapy in early-stage lung cancer? Kim: So far, there have been a couple of phase II trials that have looked at CTLA-4 blockade as well as PD-1 inhibition for patients who have gone on to … |
